Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.

The Journal of infectious diseases - 15 Apr 2005

Harrigan P Richard, Wynhoven Brian, Brumme Zabrina L, Brumme Chanson J, Sattha Beheroze, Major Jennifer C, de la Rosa Rafael, Montaner Julio S G

Abstract excerpt

Genotyping of human immunodeficiency virus type 1 (HIV-1) for antiretroviral drug resistance is routinely used both in clinical practice, to guide the selection of options for an individual's antiretroviral therapy, and in epidemiological studies, to estimate levels of antiretroviral drug resistance in a patient population. However, reliance on results of a single test can result in an underestimation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bias
Share to British Columbia

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Longitudinal Studies

Share to Time Factors

Source

Identifiers

PMID: 15776380
DOI: 10.1086/428852

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.PMID 15776380Read ↗

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.Semantic proximity Read ↗

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.Semantic proximity Read ↗

Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution.Semantic proximity Read ↗

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.Semantic proximity Read ↗

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.Semantic proximity Read ↗

Effects of drug resistance on viral load in patients failing antiretroviral therapy.Semantic proximity Read ↗

Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysis.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations.Semantic proximity Read ↗

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions.Semantic proximity Read ↗

Time trends in primary HIV-1 drug resistance among recently infected persons.Semantic proximity Read ↗

Confronting the Emergence of Drug-Resistant HIV Type 1: Impact of Antiretroviral Therapy on Individual and Population ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.